Details for New Drug Application (NDA): 210875
✉ Email this page to a colleague
NDA 210875 describes KYNMOBI, which is a drug marketed by Sumitomo Pharma Am and is included in one NDA. There are fourteen patents protecting this drug. Additional details are available on the KYNMOBI profile page.
The generic ingredient in KYNMOBI is apomorphine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the apomorphine hydrochloride profile page.
The generic ingredient in KYNMOBI is apomorphine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the apomorphine hydrochloride profile page.
Summary for 210875
| Tradename: | KYNMOBI |
| Applicant: | Sumitomo Pharma Am |
| Ingredient: | apomorphine hydrochloride |
| Patents: | 14 |
Medical Subject Heading (MeSH) Categories for 210875
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FILM;SUBLINGUAL | Strength | 10MG | ||||
| Approval Date: | May 21, 2020 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Sign Up | Patent Expiration: | Jun 11, 2030 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patented Use: | TREATMENT OF 'OFF' EPISODES IN PATIENTS WITH PARKINSON'S DISEASE | ||||||||
| Patent: | ⤷ Sign Up | Patent Expiration: | Apr 19, 2036 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | TREATMENT OF 'OFF' EPISODES IN PATIENTS WITH PARKINSON'S DISEASE | ||||||||
| Patent: | ⤷ Sign Up | Patent Expiration: | Aug 7, 2029 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Expired US Patents for NDA 210875
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sumitomo Pharma Am | KYNMOBI | apomorphine hydrochloride | FILM;SUBLINGUAL | 210875-001 | May 21, 2020 | ⤷ Sign Up | ⤷ Sign Up |
| Sumitomo Pharma Am | KYNMOBI | apomorphine hydrochloride | FILM;SUBLINGUAL | 210875-001 | May 21, 2020 | ⤷ Sign Up | ⤷ Sign Up |
| Sumitomo Pharma Am | KYNMOBI | apomorphine hydrochloride | FILM;SUBLINGUAL | 210875-005 | May 21, 2020 | ⤷ Sign Up | ⤷ Sign Up |
| Sumitomo Pharma Am | KYNMOBI | apomorphine hydrochloride | FILM;SUBLINGUAL | 210875-005 | May 21, 2020 | ⤷ Sign Up | ⤷ Sign Up |
| Sumitomo Pharma Am | KYNMOBI | apomorphine hydrochloride | FILM;SUBLINGUAL | 210875-003 | May 21, 2020 | ⤷ Sign Up | ⤷ Sign Up |
| Sumitomo Pharma Am | KYNMOBI | apomorphine hydrochloride | FILM;SUBLINGUAL | 210875-005 | May 21, 2020 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
